Steroids are natural products with widespread application and attract much attention in the field of chemical industry and medicine. In order to provide reference for further research and development of steroids, this paper mainly reviews the recent advances in the structural modification of steroids at A-ring according to the changes of different structural positions and introduction of functional groups.
JIN Jun,RAN Jian-qiang.
Advances in Structural Modification of Steroids at A-ring[J]. Chinese Pharmaceutical Journal, 2017, 52(8): 617-626 https://doi.org/10.11669/cpj.2017.08.002
[1] TAN R X, WANG J W. Steroidal Chemistry(甾体化学)[M]. Beijing:Chemical Industry Press, 2009:170-174. [2] CUI J G, LIU L, HUANG Y M. Synthesis and biological activity of steroids bearing aromatic rings and heterocycles [J]. Prog Chem(化学进展), 2014, 26(2):320-333. [3] HANSON J R. Steroids:partial synthesis in medicinal chemistry [J]. Nat Prod Rep, 2010, 27(6):887-899. [4] JASEM Y A, THIEMANN T, GANO L, et al. Fluorinated steroids and their derivatives [J]. J Fluorine Chem, 2016, 185:48-85. doi:10.1016/j.jfluchem.2016.03.009. [5] EL-DESOKY E S I, REYAD M, AFSAH E M, et al. Synthesis and chemical reactions of the steroidal hormone 17a-methyltestosterone [J]. Steroids, 2016, 105(3-5):68-95. [6] SUWANDI L S, AGOSTON G E, SHAH A J H, et al. Synthesis and antitumor activities of 3-modified 2-methoxyestradiol analogs [J]. Bioorg Med Chem Lett, 2009, 19(22):6459-6462. [7] ZEFIROV N A, ZEFIROVA O N. 2-Methoxyestradiol and its analogs. Synthesis and structure-antiproliferative activity relationship [J]. Russ J Org Chem, 2015, 51(9):1207-1216. [8] ASIRI A M, KHAN S A. Palladium (Ⅱ) complexes of NS donor ligands derived from steroidal thiosemicarbazones as antibacterial agents [J]. Molecules, 2010, 15(7):4784-4791. [9] HUANG S F, WANG H, HUANG Y M, et al. The syntheses of sodium 3-β-hydroxy-cholestane 3-sulfate and its analogues [J].Guangxi Sci(广西科学), 2008, 15(7):414-418. [10] RICHMOND V, GARRIDO S G A, MURRAY A P. Synthesis and acetylcholinesterase inhibitory activity of 2β, 3α-disulfoxy-5α-cholestan-6-one [J]. Steroids, 2011, 76(10-11):1160-1165. [11] PANCHAPAKESAN G, DHAYALAN V, MOORTHY N D, et al. Synthesis of 2-substituted 17β-hydroxy/17-methylene estratrienes and their in vitro cytotoxicity in human cancer cell cultures [J]. Steroids, 2011, 76(13):1491-1504. [12] TAKAHASHI M, YAMASHITA K, NUMAZAWA M. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids [J]. Steroids, 2010, 75(4-5):330-337. [13] YOUSUF S K, MAJEED R, AHMAD M, et al. Ring A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential [J]. Steroids, 2011,76(10):1213-1222. [14] WATARI Y, YAMAGUCHI S, TAKAHASHI M, et al. 4-and 6-(p-Sulphamoylphenyl)androstenediones:studies of aromatase. inhibitor-based oestrone sulphatase inhibition [J]. Steroids, 2010, 75(12):891-896. [15] YADAV M R, BARMADE M A, TAMBOLI R S, et al. Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer [J]. Eur J Med Chem, 2015, 105:1-38. doi:10.1016/j.ejmech.2015.09.038. [16] KADAR Z, BAJI A, ZUPKO I, et al. Efficient approach to novel 1-triazolyl-5-androstane derivatives as potent anti-proliferative agents [J]. Org Biomol Chem, 2011, 9(23):2-9. [17] FRANK E, SCHNEIDER G. Synthesis of sex hormone-derived modified steroids possessing antiproliferative activity [J]. J Steroid Biochem Mol Biol, 2013, 137:301-315. doi:10.1016/j.jsbmb.2013.02.018. [18] LU X F, YANG Z, HUANG N Y, et al. Synthesis and cytotoxic activities of 2-substituted (25R)-spirostan-1,4,6-triene-3-ones via ring-opening/elimination and ‘click’ strategy [J]. Bioorg Med Chem Lett, 2015, 25(17):3726-3729. [19] JEGHAM H, MALTAIS R, DUFOUR P, et al. Solid-phase chemical synthesis and in vitro biological evaluation of novel 2β-piperazino-(20R)-5a-pregnane-3a,20-diol N-derivatives as anti-leukemic agents [J]. Steroids, 2012, 77(13):1403-1418. [20] YAMANSAROV E Y, KAZAKOVA O B, MEDVEDEVA N I, et al. First synthesis of steroidal 1,2,4-trioxolanes [J]. Russ J Org Chem, 2014, 50(7):1043-1047. [21] DAS A M, HAZARIKA M P. Synthesis of some novel steroidal 1,2,4,5-tetraoxanes [J]. RSC Adv, 2015, 5(26):19818-19822. [22] SHAMSUZZAMAN, SIDDIQUI T, ALAM M G, et al. Synthesis, characterization and anticancer studies of new steroidal oxadiazole, pyrrole and pyrazole derivatives [J]. J Saudi Chem Soc, 2015, 19(4):387-391. [23] SHAMSUZZAMAN, BAQI K A, ALI A, et al. Synthesis, characterization, biological evaluation and molecular docking of steroidal spirothiazolidinones [J]. J Mol Struct, 2015, 1085:104-114. doi:10.1016/j.molstruc.2014.12.036. [24] LEI M, XIAO Z Y, MA B, et al. Synthesis and biological evaluation of bufalin-3-yl nitrogen-containing-carbamate derivatives as anticancer agents [J]. Steroids, 2016, 108:56-60. doi:10.1016/j.steroids.2016.01.011. [25] JURASEK M, DZUBAK P, SEDLAK D, et al. Preparation, preliminary screening of new types of steroid conjugates and their activities on steroid receptors [J]. Steroids, 2013, 78(3):356-361. [26] LIU L, JIA L Y, HUANG Y M, et al. Synthesis of 3-substituted pregn-4-en-6, 20-diones containing nitrogen [J]. Chem Reagents(化学试剂), 2013, 35(4):309-312. [27] VARELA C, ELISIARIO J, SILVA T D, et al. New structure-activity relationships of a-and d-ring modified steroidal aromatase inhibitors:design synthesis, and biochemical evaluation [J]. J Med Chem, 2012, 55(8):3992-4002. [28] SAKAC M, GAKOVIC A, DJURENDIC E, et al. Synthesis and biological evaluation of a series of A, B-ring modified 16,17-secoandrostane derivatives [J]. Bioorg Chem, 2008, 36(3):128-132. [29] YADVA M R, SABALE P M, GIRIDHAR R, et al. Steroidal carbonitriles as potential aromatase inhibitors [J]. Steroids, 2012, 77(8):850-857. [30] MOSTAFA Y A, KRALT B, TAYLOR S D, et al. A-ring substituted 17β-arylsulfonamides of 17β-aminoestra-1,3,5(10)-trien-3-ol as highly potent reversible inhibitors of steroid sulfatase [J]. Bioorg Med Chem, 2015, 23(17):5681-5692. [31] KIURU P S, WAHALA K. Short synthesis of 2-methoxyestradiol and 2-hydroxyestradiol [J]. Steroids, 2003, 68(4):373-375. [32] KIM S, KIM Y U, MA E. Synthesis and 5α-reductase inhibitory activity of c21 steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes [J]. Molecules, 2012, 17(1):355-368. [33] HUANG Y M, CUI J, CHEN, et al. Synthesis and antiproliferative activity of some steroidal lactams [J]. Steroids, 2011, 76(12):1346-1350. [34] EL-FAR M, ELMEGEED G A, ESKANDER E F, et al. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents [J]. Eur J Med Chem, 2009, 44(10):3936-3946. [35] GOGOI S, SHEKARRAO K, DUARAH A, et al. A microwave promoted solvent-free approach to steroidal quinolines and their in vitro evaluation for antimicrobial activities [J]. Steroids, 2012, 77(13):1438-1445. [36] BAJI A, GYOVAI A, WOLFLING J, et al. Microwave-assisted one-pot synthesis of steroid-quinoline hybrids and an evaluation of their antiproliferative activities on gynecological cancer cell lines [J]. RSC Adv, 2016, 6(33):27501-27516. [37] YADAV M R, SABALE P M, GIRIDHAR, et al. Synthesis of some novel androstanes as potential aromatase inhibitors [J]. Steroids, 2011, 76(5):464-470. [38] LAURO F V, FRANCISCO D C, ELODIA G C, et al. Synthesis and antibacterial activity evaluation of two androgen derivatives [J]. Steroids, 2015,93(suppl C):8-15.